## Abstract Percutaneous balloon aortic valvuloplasty has been used as a therapeutic option for patients with severe aortic stenosis who are not candidates for aortic valve replacement. This procedure has been limited by both the high rate of aortic valve restenosis and high procedural morbidity re
Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty
β Scribed by Eric Yamen; David V. Daniels; HoHai Van; Alan C. Yeung; William F. Fearon
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 285 KB
- Volume
- 75
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objectives: To determine the safety and immediate efficacy after balloon aortic valvuloplasty (BAV) with a new, lowβprofile balloon. Background: BAV has a continuing role in the management of highβrisk patients with severe aortic stenosis (AS). BAV with traditional noncompliant balloons requires a large femoral arteriotomy and is associated with high rates of access site complications. Methods: We retrospectively reviewed medical records of 20 consecutive patients undergoing BAV for severe AS. Retrograde transfemoral BAV was performed with a lowβprofile, compliant valvuloplasty balloon. Before and after BAV, transaortic gradients were measured invasively and by echocardiography, and aortic valve area (AVA) calculated. Access site complications, functional class and survival were recorded. Results: Patients were 79 Β± 12 years old and had an estimated mortality from open aortic valve replacement of (12.5 Β± 9.6)%. By catheterization, mean aortic gradient fell from 44 Β± 15 to 29 Β± 10 mm Hg (P < 0.001) and AVA increased from 0.63 Β± 0.22 to 0.89 Β± 0.33 cm^2^ (P < 0.001). New York Heart Association functional class improved from 3.5 Β± 0.7 to 2.7 Β± 0.8. Procedural mortality was 0%. There were no vascular complications or significant worsening of aortic regurgitation. Conclusion: Transfemoral BAV using a lowβprofile compliant balloon is feasible with acceptable immediate results and safety. Β© 2009 WileyβLiss, Inc.
π SIMILAR VOLUMES
We describe the use of the Inoue balloon to dilate the aortic valve by the physiologic antegrade route during pregnancy. A 27-year-old pregnant woman with severe aortic stenosis presented with progressive dyspnea and presyncope at 26 weeks of pregnancy. She subsequently underwent percutaneous valvul
For infants with valvar aortic stenosis, balloon aortic valvuloplasty has supplanted surgical valvotomy as the initial treatment of choice at most institutions. Technological innovations have resulted in further miniaturization of balloon dilation catheters, allowing this procedure to be performed t